Takagi A, Takada K, Sai K, Momma J, Aida Y, Suzuki S, Naitoh K, Tobe M, Hasegawa R, Kurokawa Y
Division of Toxicology, National Institute of Health Sciences, Tokyo, Japan.
J Appl Toxicol. 1996 Jan-Feb;16(1):15-23. doi: 10.1002/(SICI)1099-1263(199601)16:1<15::AID-JAT288>3.0.CO;2-N.
Groups of 30 Wistar rats of each sex were treated with 2,2'-methylenebis(4-ethyl-6-tert-butylphenol) (MBEBP) in the diet at levels of 0, 0.03, 0.1 and 0.3% for up to 18 months. In both sexes, survival rates of treated groups were similar to those of the controls. Body weight gain was depressed (0.3% group in males, 0.1 and 0.3% groups in females). Slight anaemia (0.3% groups in both sexes) and increase of blood urea nitrogen (0.3% groups in both sexes) were observed. Histopathologically, vacuolization of the parathyroid gland cells (0.3% group in males and all treated groups in females) and degenerative changes of the kidney (0.1 and 0.3% groups in males) were observed. No neoplastic responses following MBEBP administration were noted. From these results, the no-observed-adverse-effect level (NOAEL) for MBEBP toxicity was estimated as 12 mg kg-1 body wt. day-1 in male rats. In female rats, the lowest-observed-adverse-effect level (LOAEL) was estimated as 15 mg kg-1 body wt. day-1.
将每组30只不同性别的Wistar大鼠用2,2'-亚甲基双(4-乙基-6-叔丁基苯酚)(MBEBP)进行处理,在饮食中的添加水平分别为0%、0.03%、0.1%和0.3%,持续18个月。在两种性别中,处理组的存活率与对照组相似。体重增加受到抑制(雄性0.3%组,雌性0.1%和0.3%组)。观察到轻微贫血(两性的0.3%组)和血尿素氮增加(两性的0.3%组)。组织病理学上,观察到甲状旁腺细胞空泡化(雄性0.3%组和雌性所有处理组)和肾脏退行性变化(雄性0.1%和0.3%组)。未观察到MBEBP给药后的肿瘤反应。根据这些结果,雄性大鼠中MBEBP毒性的未观察到有害作用水平(NOAEL)估计为12毫克/千克体重·天-1。在雌性大鼠中,最低观察到有害作用水平(LOAEL)估计为15毫克/千克体重·天-1。